Omega Therapeutics (OMGA) Short Interest Ratio & Short Volume $0.12 -0.03 (-21.83%) Closing price 02/24/2025Extended Trading$0.12 0.00 (0.00%) As of 02/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Omega Therapeutics Short Interest DataOmega Therapeutics (OMGA) has a short interest of 5.21 million shares, representing 26.99% of the float (the number of shares available for trading by the public). This marks a 5.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 3.64 million shares to cover all short positions.Current Short Interest5,210,000 sharesPrevious Short Interest4,950,000 sharesChange Vs. Previous Month+5.25%Dollar Volume Sold Short$2.55 millionShort Interest Ratio0.9 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares55,366,000 sharesFloat Size19,300,000 sharesShort Percent of Float26.99%Today's Trading Volume4,811,744 sharesAverage Trading Volume3,644,240 sharesToday's Volume Vs. Average132% Short Selling Omega Therapeutics? Sign up to receive the latest short interest report for Omega Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMGA Short Interest Over TimeOMGA Days to Cover Over TimeOMGA Percentage of Float Shorted Over Time Omega Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20255,210,000 shares $2.55 million +5.3%27.0%0.9 $0.49 1/15/20254,950,000 shares $3.14 million -3.7%25.6%14.4 $0.63 12/31/20245,140,000 shares $3.83 million -6.0%26.6%15.4 $0.75 12/15/20245,470,000 shares $5.30 million -3.5%28.3%17.6 $0.97 11/30/20245,670,000 shares $5.01 million -11.1%29.5%18.8 $0.88 11/15/20246,380,000 shares $5.29 million +0.3%33.2%22.6 $0.83 10/31/20246,360,000 shares $7.38 million +5.5%31.1%26.5 $1.16 10/15/20246,030,000 shares $5.39 million +7.5%29.5%25 $0.89 9/30/20245,610,000 shares $6.84 million -0.2%27.4%27.2 $1.22 9/15/20245,620,000 shares $7.47 million +0.9%27.5%18.5 $1.33 Get the Latest News and Ratings for OMGA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20245,570,000 shares $8.19 million -0.7%27.2%15.4 $1.47 8/15/20245,610,000 shares $8.58 million +5.1%27.4%13.3 $1.53 7/31/20245,340,000 shares $9.93 million No Change26.1%11.4 $1.86 7/15/20245,340,000 shares $10.41 million -5.2%26.1%11.2 $1.95 6/30/20245,630,000 shares $11.65 million +7.4%27.5%11.7 $2.07 6/15/20245,240,000 shares $10.64 million +0.6%25.6%12.7 $2.03 5/31/20245,210,000 shares $10.32 million +5.0%25.4%13.9 $1.98 5/15/20244,960,000 shares $11.31 million +10.2%24.2%13.4 $2.28 4/30/20244,500,000 shares $10.04 million +1.6%22.0%11.1 $2.23 4/15/20244,430,000 shares $11.14 million +9.7%21.7%9.6 $2.52 3/31/20244,040,000 shares $14.75 million +4.1%19.8%5.3 $3.65 3/15/20243,880,000 shares $14.05 million +4.3%19.0%1.8 $3.62 2/29/20243,720,000 shares $15.29 million +12.4%18.2%1.8 $4.11 2/15/20243,310,000 shares $14.07 million +5.8%16.2%1.6 $4.25 1/31/20243,130,000 shares $11.42 million -13.5%14.7%1.6 $3.65 1/15/20243,620,000 shares $15.75 million +138.2%17.0%1.9 $4.35 12/31/20231,520,000 shares $4.58 million +2.7%7.1%0.9 $3.01 12/15/20231,480,000 shares $3.66 million -11.9%6.9%5.9 $2.47 11/30/20231,680,000 shares $3.85 million +0.6%7.9%7.5 $2.29 11/15/20231,670,000 shares $3.11 million -13.0%7.8%8.6 $1.86 10/31/20231,920,000 shares $2.63 million -6.8%9.0%10.3 $1.37 10/15/20232,060,000 shares $3.61 million +7.9%9.7%14 $1.75 9/30/20231,910,000 shares $4.11 million -11.2%9.0%13.8 $2.15 9/15/20232,150,000 shares $7.10 million +4.9%10.1%12.9 $3.30 8/31/20232,050,000 shares $7.52 million +12.6%9.6%11.9 $3.67 8/15/20231,820,000 shares $6.30 million +4.0%8.6%10.5 $3.46 7/31/20231,750,000 shares $9.78 million +7.4%8.2%10.2 $5.59 7/15/20231,630,000 shares $7.53 million +15.6%7.6%9.9 $4.62 6/30/20231,410,000 shares $7.90 million +33.0%6.6%8.8 $5.60 6/15/20231,060,000 shares $8.43 million +1.0%5.0%7 $7.95This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin 5/31/20231,050,000 shares $7.97 million +8.2%6.4%10.4 $7.59 5/15/2023970,900 shares $8.23 million -1.9%6.7%10.3 $8.48 4/30/2023989,900 shares $7.58 million +7.2%6.5%10.5 $7.66 4/15/2023923,600 shares $6.98 million +34.0%6.0%10.2 $7.56 3/31/2023689,300 shares $4.16 million +65.1%4.5%7.2 $6.03 3/15/2023417,600 shares $2.83 million +10.8%2.7%5.2 $6.78 2/28/2023376,800 shares $2.43 million -5.0%2.2%5.9 $6.46 2/15/2023396,800 shares $2.20 million +14.3%2.0%6.6 $5.55 1/31/2023347,200 shares $2.73 million +6.3%2.0%6.1 $7.85 1/15/2023326,600 shares $2.83 million +3.5%1.8%6.6 $8.65 12/30/2022315,700 shares $1.80 million +0.1%1.8%8.2 $5.71 12/15/2022315,500 shares $1.92 million -3.9%1.8%7.3 $6.10 11/30/2022328,300 shares $2.30 million -6.4%1.9%5 $7.00 11/15/2022350,800 shares $2.17 million -6.7%2.0%5.4 $6.20 10/31/2022375,900 shares $1.81 million +2.2%2.1%5.2 $4.81 10/15/2022368,000 shares $1.69 million +15.0%2.1%4.7 $4.60 9/30/2022320,100 shares $1.73 million +15.3%1.8%3.8 $5.42 9/15/2022277,600 shares $1.71 million -14.0%1.6%2 $6.17 8/31/2022322,900 shares $1.44 million -13.6%1.8%2.4 $4.47 8/15/2022373,900 shares $1.87 million -14.9%2.1%2.3 $5.00 7/31/2022439,400 shares $2.24 million -18.5%2.5%2.5 $5.10 7/15/2022538,800 shares $2.32 million -24.3%3.1%2.8 $4.31 6/30/2022711,900 shares $2.71 million -37.0%4.1%3.6 $3.80 6/15/20221,130,000 shares $3.17 million +1.8%6.5%5.9 $2.81 5/31/20221,110,000 shares $2.52 million +5.7%6.4%6.1 $2.27 5/15/20221,050,000 shares $3.01 million +41.3%6.0%6.4 $2.87 4/30/2022743,000 shares $2.53 million -29.9%4.3%4.5 $3.41 4/15/20221,060,000 shares $6.22 million -17.2%6.1%7.3 $5.87 3/31/20221,280,000 shares $7.99 million +48.3%7.3%9.2 $6.24 3/15/2022863,100 shares $6.99 million +16.4%5.0%6.1 $8.10 2/28/2022741,600 shares $8.80 million +6.3%4.3%6.9 $11.87 2/15/2022697,500 shares $7.91 million -3.3%4.0%6.9 $11.34 1/31/2022721,400 shares $8.20 million +5.8%4.1%8.4 $11.36 1/15/2022681,700 shares $7.27 million +9.1%3.9%7.7 $10.66 12/31/2021624,700 shares $7.08 million No Change3.6%6.8 $11.33 OMGA Short Interest - Frequently Asked Questions What is Omega Therapeutics' current short interest? Short interest is the volume of Omega Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 5,210,000 shares of OMGA short. 26.99% of Omega Therapeutics' shares are currently sold short. Learn More on Omega Therapeutics' current short interest. What is a good short interest ratio for Omega Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMGA shares currently have a short interest ratio of 1.0. Learn More on Omega Therapeutics's short interest ratio. What is a good short interest percentage for Omega Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.99% of Omega Therapeutics' floating shares are currently sold short. Is Omega Therapeutics' short interest increasing or decreasing? Omega Therapeutics saw a increase in short interest in January. As of January 31st, there was short interest totaling 5,210,000 shares, an increase of 5.3% from the previous total of 4,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Omega Therapeutics' float size? Omega Therapeutics currently has issued a total of 55,366,000 shares. Some of Omega Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Omega Therapeutics currently has a public float of 19,300,000 shares. How does Omega Therapeutics' short interest compare to its competitors? 26.99% of Omega Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Omega Therapeutics: Coeptis Therapeutics Holdings, Inc. (1.62%), Tempest Therapeutics, Inc. (9.67%), NeuroSense Therapeutics Ltd. (2.27%), Cadrenal Therapeutics, Inc. (1.50%), Cognition Therapeutics, Inc. (3.88%), ALX Oncology Holdings Inc. (14.41%), Cara Therapeutics, Inc. (1.74%), Tenax Therapeutics, Inc. (9.28%), Ovid Therapeutics (2.08%), Cyclo Therapeutics, Inc. (3.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Omega Therapeutics stock? Short selling OMGA is an investing strategy that aims to generate trading profit from Omega Therapeutics as its price is falling. OMGA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Omega Therapeutics? A short squeeze for Omega Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OMGA, which in turn drives the price of the stock up even further. How often is Omega Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMGA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies COEP Short Interest TPST Short Interest NRSN Short Interest CVKD Short Interest CGTX Short Interest ALXO Short Interest CARA Short Interest TENX Short Interest OVID Short Interest CYTH Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMGA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMGA Stock Alerts